Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv-Fc) (BSCFV-164)

Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv-Fc) is formed by fusing two different scFv fragments to the hinge and Fc regions, in which the Fc region are engineered by KIH. Two of scFv moiety has the antibody variable domain of either anti-gp40 specificity or anti-TFRC specificity, which produces bivalent IgG-like molecules with desired characteristics of intact antibodies. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.

Datasheet INQUIRY

Specifications

Targets

gp40 & TFRC

Type

scFv-Fc

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Colon cancer; Ovarian cancer

Targets

Target 1

gp40

Alternative Names

gp40; glycoprotein 40; adenocarcinoma-associated antigen

Target 2

TFRC

Gene ID

7037

UniProt ID

P02786

Alternative Names

TFRC; transferrin receptor; T9; TR; TFR; p90; CD71; TFR1; TRFR; transferrin receptor protein 1; transferrin receptor (p90, CD71); IMD46

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv-Fc) (BSCFV-164). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (scFv-Fc) (CAT#: BSCFV-164)

Specifications

Targets

Customer Reviews and Q&As